Dan Russell Zanoria

Coordinator, Financial Operations at Health & Wellness Partners, LLC (HWP)

Dan Russell Zanoria is a finance professional with a diverse background in financial operations, analysis, and management. Currently serving as Coordinator of Financial Operations at Health & Wellness Partners, LLC since December 2022, Dan Russell Zanoria is responsible for reporting on payments and expenditures for contracted events. Previous roles include Political Cash Analyst at Univision, where Dan Russell Zanoria handled payments for political advertisements, and Head of the Shipping Department at YourLifeRx, Inc., overseeing nationwide medicine shipments. Dan Russell Zanoria has also held positions in retail management at Walgreens, operational support at M&T Bank, and administration in the legal field at the Law Office of Walter Janneck. With military experience as an Infantryman and Cavalry Scout in the US Army, Dan Russell Zanoria possesses strong leadership and organizational skills that complement a solid educational foundation, including an MBA in Finance from Hult International Business School and a Bachelor's degree in Finance from Fairleigh Dickinson University.

Location

Bergenfield, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Health & Wellness Partners, LLC (HWP)

Founded in 2005, Health & Wellness Partners, LLC (HWP) is a leading provider of medical communications solutions to global life sciences companies. HWP currently provides three synergistic service offerings: medical affairs, medical marketing and speaker bureau. Each service offering is seeded in expert strategy, scientific content and proprietary technology enabling solutions that allow HWP to deliver tailored, high-impact educational engagements. HWP has built a reputation for achieving outcomes that are measured across customer type and delivery method, whether it be in-person, digital or virtual. HWP supports life-science companies across a multitude of therapeutic areas and disease states, from early preclinical to patent expiry.